- What other names is Ascorbigen known by?
- What is Ascorbigen?
- How does Ascorbigen work?
- Are there safety concerns?
- Are there any interactions with medications?
- Dosing considerations for Ascorbigen.
People take ascorbigen for treating fibromyalgia and preventing breast cancer.
Insufficient Evidence to Rate Effectiveness for...
- Fibromyalgia. Developing research suggests that ascorbigen and broccoli powder might reduce pain and other symptoms in people with fibromyalgia.
- Breast cancer.
- Other conditions.
Quick GuideVitamin D Deficiency: How Much Vitamin D Is Enough?
intestinal gas, bloating, and unpleasant taste.
Special Precautions & Warnings:Pregnancy and breast-feeding: Not enough is known about the use of ascorbigen during pregnancy and breast-feeding. Stay on the safe side and avoid use.
Medications changed by the liver (Cytochrome P450 1A2 [CYP1A2] substrates)
Interaction Rating: Moderate Be cautious with this combination.
Talk with your health provider.
Some medications are changed and broken down by the liver. Ascorbigen might increase how quickly the liver breaks down some medications. Taking ascorbigen along with some medications that are changed by the liver might decrease the effects of some medications.
Some of these medications that are changed by the liver include clozapine (Clozaril), cyclobenzaprine (Flexeril), fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), olanzapine (Zyprexa), pentazocine (Talwin), propranolol (Inderal), tacrine (Cognex), theophylline, zileuton (Zyflo), zolmitriptan (Zomig), and others.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Last Editorial Review: 3/29/2011